Dell Faulkingham has sold AKBA and made no open-market buys since Jun 2020
SVP and CCO at Akebia Therapeutics, Inc.
SEC CIK 0001776024 · Filings on SEC.gov ↗
$0Bought
$103KSold
NoneLast buy
Every filing
2 filings since Jun 2020, newest first
Filings come from SEC EDGAR. Not investment advice.